Prevalence and Spectrum of Germline BRCA1 and BRCA2 Variants of Uncertain Significance in Breast/Ovarian Cancer: Mysterious Signals From the Genome
By Fanale D, Fiorino A, Incorvaia L, Dimino A, Filorizzo C, Bono M, Cancelliere D, Calò V, Brando C, Corsini LR, Sciacchitano R, Magrin L, Pivetti A, Pedone E, Madonia G, Cucinella A, Badalamenti G, Russo A and Bazan V (2021). Front. Oncol. 11:682445. doi: 10.3389/fonc.2021.682445
Due to a production error, there was a mistake in Table 2 as published. Some BRCA1 variants were incorrectly listed. The correct Table 2 appears below. The publisher apologizes for this mistake.
Table 2 BRCA1 gene variants of unclear significance harbored by patients with breast and ovarian cancers.
The original version of this article has been updated.
Keywords: BRCA1, BRCA2, breast cancer, genetic testing, ovarian cancer, variants of uncertain significance (VUS)
Citation: Frontiers Production Office (2022) Erratum: Prevalence and Spectrum of Germline BRCA1 and BRCA2 Variants of Uncertain Significance in Breast/Ovarian Cancer: Mysterious Signals From the Genome. Front. Oncol. 12:920342. doi: 10.3389/fonc.2022.920342
Received: 14 April 2022; Accepted: 14 April 2022;
Published: 04 May 2022.
Approved by:
Frontiers Editorial Office, Frontiers Media SA, SwitzerlandCopyright © 2022 Frontiers Production Office. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Frontiers Production Office, cHJvZHVjdGlvbi5vZmZpY2VAZnJvbnRpZXJzaW4ub3Jn